202 related articles for article (PubMed ID: 21729304)
61. Plasma concentrations of angiogenesis-related molecules in patients with pancreatic cancer.
Sakamoto H; Kimura H; Sekijima M; Matsumoto K; Arao T; Chikugo T; Yamada Y; Kitano M; Ito A; Takeyama Y; Kudo M; Nishio K
Jpn J Clin Oncol; 2012 Feb; 42(2):105-12. PubMed ID: 22167663
[TBL] [Abstract][Full Text] [Related]
62. Role of platelet-derived growth factor-AB in tumour growth and angiogenesis in relation with other angiogenic cytokines in multiple myeloma.
Tsirakis G; Pappa CA; Kanellou P; Stratinaki MA; Xekalou A; Psarakis FE; Sakellaris G; Alegakis A; Stathopoulos EN; Alexandrakis MG
Hematol Oncol; 2012 Sep; 30(3):131-6. PubMed ID: 21919032
[TBL] [Abstract][Full Text] [Related]
63. Clinical impact of circulating LAPTM4B-35 in pancreatic ductal adenocarcinoma.
Yang Z; Senninger N; Flammang I; Ye Q; Dhayat SA
J Cancer Res Clin Oncol; 2019 May; 145(5):1165-1178. PubMed ID: 30778748
[TBL] [Abstract][Full Text] [Related]
64. Serum gamma-glutamyltransferase and the overall survival of metastatic pancreatic cancer.
Xiao Y; Yang H; Lu J; Li D; Xu C; Risch HA
BMC Cancer; 2019 Oct; 19(1):1020. PubMed ID: 31664937
[TBL] [Abstract][Full Text] [Related]
65. The relationship between SPARC expression in primary tumor and metastatic lymph node of resected pancreatic cancer patients and patients' survival.
Yu XZ; Guo ZY; Di Y; Yang F; Ouyang Q; Fu DL; Jin C
Hepatobiliary Pancreat Dis Int; 2017 Feb; 16(1):104-109. PubMed ID: 28119265
[TBL] [Abstract][Full Text] [Related]
66. Expression of angiogenic basic fibroblast growth factor, platelet derived growth factor, thrombospondin-1 and their receptors at the porcine maternal-fetal interface.
Edwards AK; van den Heuvel MJ; Wessels JM; Lamarre J; Croy BA; Tayade C
Reprod Biol Endocrinol; 2011 Jan; 9():5. PubMed ID: 21241502
[TBL] [Abstract][Full Text] [Related]
67. Expression of vasohibin-2 in pancreatic ductal adenocarcinoma promotes tumor progression and is associated with a poor clinical outcome.
Kim JC; Kim KT; Park JT; Kim HJ; Sato Y; Kim HS
Hepatogastroenterology; 2015; 62(138):251-6. PubMed ID: 25916042
[TBL] [Abstract][Full Text] [Related]
68. Measurement of circulating levels of VEGF-A, -C, and -D and their receptors, VEGFR-1 and -2 in gastric adenocarcinoma.
Al-Moundhri MS; Al-Shukaili A; Al-Nabhani M; Al-Bahrani B; Burney IA; Rizivi A; Ganguly SS
World J Gastroenterol; 2008 Jun; 14(24):3879-83. PubMed ID: 18609713
[TBL] [Abstract][Full Text] [Related]
69. Prognostic and predictive value of vascular endothelial growth factor and its soluble receptors, VEGFR-1 and VEGFR-2 levels in the sera of small cell lung cancer patients.
Ustuner Z; Saip P; Yasasever V; Vural B; Yazar A; Bal C; Ozturk B; Ozbek U; Topuz E
Med Oncol; 2008; 25(4):394-9. PubMed ID: 18317954
[TBL] [Abstract][Full Text] [Related]
70. PDGF(BB) increases myocardial production of VEGF: shift in VEGF mRNA splice variants after direct injection of bFGF, PDGF(BB), and PDGF(AB).
Affleck DG; Bull DA; Bailey SH; Albanil A; Connors R; Stringham JC; Karwande SV
J Surg Res; 2002 Oct; 107(2):203-9. PubMed ID: 12429176
[TBL] [Abstract][Full Text] [Related]
71. Low RASSF6 expression in pancreatic ductal adenocarcinoma is associated with poor survival.
Ye HL; Li DD; Lin Q; Zhou Y; Zhou QB; Zeng B; Fu ZQ; Gao WC; Liu YM; Chen RW; Li ZH; Chen RF
World J Gastroenterol; 2015 Jun; 21(21):6621-30. PubMed ID: 26074700
[TBL] [Abstract][Full Text] [Related]
72. Platelet-derived growth factor (PDGF) in human acute myelogenous leukemia: PDGF receptor expression, endogenous PDGF release and responsiveness to exogenous PDGF isoforms by in vitro cultured acute myelogenous leukemia blasts.
Foss B; Ulvestad E; Bruserud Ø
Eur J Haematol; 2001 Oct; 67(4):267-78. PubMed ID: 11860452
[TBL] [Abstract][Full Text] [Related]
73. Predicting the treatment effect of sorafenib using serum angiogenesis markers in patients with hepatocellular carcinoma.
Miyahara K; Nouso K; Tomoda T; Kobayashi S; Hagihara H; Kuwaki K; Toshimori J; Onishi H; Ikeda F; Miyake Y; Nakamura S; Shiraha H; Takaki A; Yamamoto K
J Gastroenterol Hepatol; 2011 Nov; 26(11):1604-11. PubMed ID: 22011296
[TBL] [Abstract][Full Text] [Related]
74. Prognostic significance of platelet-derived growth factor-BB expression in human esophageal squamous cell carcinomas.
Matsumoto S; Yamada Y; Narikiyo M; Ueno M; Tamaki H; Miki K; Wakatsuki K; Enomoto K; Yokotani T; Nakajima Y
Anticancer Res; 2007; 27(4B):2409-14. PubMed ID: 17695532
[TBL] [Abstract][Full Text] [Related]
75. Relationship between autophagy and perineural invasion, clinicopathological features, and prognosis in pancreatic cancer.
Yang YH; Liu JB; Gui Y; Lei LL; Zhang SJ
World J Gastroenterol; 2017 Oct; 23(40):7232-7241. PubMed ID: 29142470
[TBL] [Abstract][Full Text] [Related]
76. Serum cytokine profile in patients with pancreatic cancer.
Torres C; Perales S; Alejandre MJ; Iglesias J; Palomino RJ; Martin M; Caba O; Prados JC; Aránega A; Delgado JR; Irigoyen A; Ortuño FM; Rojas I; Linares A
Pancreas; 2014 Oct; 43(7):1042-9. PubMed ID: 24979617
[TBL] [Abstract][Full Text] [Related]
77. Circulating stem cell vary with NYHA stage in heart failure patients.
Fortini C; Toffoletto B; Fucili A; Puppato E; Olivares A; Beltrami AP; Fiorelli V; Bergamin N; Cesselli D; Morelli C; Francolini G; Ferrari R; Beltrami CA
J Cell Mol Med; 2011 Aug; 15(8):1726-36. PubMed ID: 21029373
[TBL] [Abstract][Full Text] [Related]
78. Measurement of 45 cytokine, chemokine and growth factors in established cell culture supernatants and autologous serum from advanced melanoma patients.
Montoyo-Pujol YG; Wang X; Bermúdez-Sánchez S; Martin A; Almazan F; López-Nevot MÁ
Carcinogenesis; 2021 May; 42(5):714-723. PubMed ID: 33421057
[TBL] [Abstract][Full Text] [Related]
79. Emerging roles of endoglin/CD105 and angiogenic cytokines for disease development and progression in multiple myeloma patients.
Pappa CA; Alexandrakis MG; Boula A; Psarakis FE; Kolovou A; Bantouna V; Stavroulaki E; Tsirakis G
Hematol Oncol; 2013 Dec; 31(4):201-5. PubMed ID: 23576184
[TBL] [Abstract][Full Text] [Related]
80. Hepatocyte growth factor/scatter factor differentially regulates expression of proangiogenic factors through Egr-1 in head and neck squamous cell carcinoma.
Worden B; Yang XP; Lee TL; Bagain L; Yeh NT; Cohen JG; Van Waes C; Chen Z
Cancer Res; 2005 Aug; 65(16):7071-80. PubMed ID: 16103054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
